Clinical Trial Update: Bioavailability of Intranasal Dexmedetomidine [Phase 4]

View source ↗

Summary

Phase 4 trial update on the bioavailability of intranasal dexmedetomidine, focusing on pharmacokinetics and arthritis-related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia
• Arthritis of the Hip
• Arthritis of the Knee

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Turku University Hospital | Conditions: Pharmacokinetics, Arthritis Knee | Phase 4 | Status: COMPLETED